RE:RE:RE:RE:I am new to this stock. Bought this morning @1.40$I think folks are doing this just to annoy me. On the other board, Cabel posted that it was Dec 4th. Here, G1945V is posting Dec 6th. Take the average and you will find the truth!!!! Check the facts for yourself! Dec 5th!!!
CTAD final program Two CTAD oral presentations on Dec 5th (including BETonMACE cognition sub-study).
PRESENTER 3: The epigenetic inhibitor APABETALONE corrects pathophysiological brain endothelial and microglial cell activation that contributes to neurodegenerative disease Ewelina Kulikowski, SVP Research and Development, Resverlogix Corporation, Calgary, Canada
PRESENTER 4: Epigenetics, the BET-system, Alzheimer’s Disease and Vascular Cognitive Impairment; The BETonMACE study and effects of apabetalone 100 mg b.i.d. two years treatment on cognition in diabetes patients with established cardiovascular disease Jeffrey Cummings, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA
Also a poster during CTAD (not sure of the date): P212 Epigenetic Modulator Apabetalone Inhibits Monocyte Adhesion To Brain Endothelial Cells By Downregulating Key Neuroinflammation Markers In Vitro And In Vivo